119 related articles for article (PubMed ID: 38058074)
21. SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.
Peng C; Zhao H; Song Y; Chen W; Wang X; Liu X; Zhang C; Zhao J; Li J; Cheng G; Wu D; Gao C; Wang X
J Exp Clin Cancer Res; 2017 Oct; 36(1):141. PubMed ID: 29020987
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the proliferation, invasion, migration, and epithelial-mesenchymal transition of prostate cancer cells through the action of
Zhang B; Zhu Z; Zhang X; Li F; Ding A
Transl Androl Urol; 2022 Jan; 11(1):53-66. PubMed ID: 35242641
[TBL] [Abstract][Full Text] [Related]
23. Qinggan Huoxue Recipe suppresses epithelial-to-mesenchymal transition in alcoholic liver fibrosis through TGF-β1/Smad signaling pathway.
Wu T; Chen JM; Xiao TG; Shu XB; Xu HC; Yang LL; Xing LJ; Zheng PY; Ji G
World J Gastroenterol; 2016 May; 22(19):4695-706. PubMed ID: 27217701
[TBL] [Abstract][Full Text] [Related]
24. PDLIM2 can inactivate the TGF-β/Smad pathway to inhibit the malignant behavior of ovarian cancer cells.
Lv W; Guo H; Wang J; Ma R; Niu L; Shang Y
Cell Biochem Funct; 2023 Jul; 41(5):542-552. PubMed ID: 37170668
[TBL] [Abstract][Full Text] [Related]
25. microRNA-539 functions as a tumor suppressor in papillary thyroid carcinoma via the transforming growth factor β1/Smads signaling pathway by targeting secretory leukocyte protease inhibitor.
Xu CB; Liu XS; Li JQ; Zhao X; Xin D; Yu D
J Cell Biochem; 2019 Jun; 120(6):10830-10846. PubMed ID: 30706537
[TBL] [Abstract][Full Text] [Related]
26. Mammalian Target of Rapamycin (mTOR) Regulates Transforming Growth Factor-β1 (TGF-β1)-Induced Epithelial-Mesenchymal Transition via Decreased Pyruvate Kinase M2 (PKM2) Expression in Cervical Cancer Cells.
Cheng KY; Hao M
Med Sci Monit; 2017 Apr; 23():2017-2028. PubMed ID: 28446743
[TBL] [Abstract][Full Text] [Related]
27. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
Da C; Liu Y; Zhan Y; Liu K; Wang R
Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
[TBL] [Abstract][Full Text] [Related]
28. JAK/STAT3 signaling is required for TGF-β-induced epithelial-mesenchymal transition in lung cancer cells.
Liu RY; Zeng Y; Lei Z; Wang L; Yang H; Liu Z; Zhao J; Zhang HT
Int J Oncol; 2014 May; 44(5):1643-51. PubMed ID: 24573038
[TBL] [Abstract][Full Text] [Related]
29. PTBP3 mediates TGF-β-induced EMT and metastasis of lung adenocarcinoma.
Dong C; Wu K; Gu S; Wang W; Xie S; Zhou Y
Cell Cycle; 2022 Jul; 21(13):1406-1421. PubMed ID: 35323096
[TBL] [Abstract][Full Text] [Related]
30. Epithelial-mesenchymal transition via transforming growth factor beta in pancreatic cancer is potentiated by the inflammatory glycoprotein leucine-rich alpha-2 glycoprotein.
Otsuru T; Kobayashi S; Wada H; Takahashi T; Gotoh K; Iwagami Y; Yamada D; Noda T; Asaoka T; Serada S; Fujimoto M; Eguchi H; Mori M; Doki Y; Naka T
Cancer Sci; 2019 Mar; 110(3):985-996. PubMed ID: 30575211
[TBL] [Abstract][Full Text] [Related]
31. Numb-PRRL promotes TGF-β1- and EGF-induced epithelial-to-mesenchymal transition in pancreatic cancer.
Sheng W; Tang J; Cao R; Shi X; Ma Y; Dong M
Cell Death Dis; 2022 Feb; 13(2):173. PubMed ID: 35197444
[TBL] [Abstract][Full Text] [Related]
32. Effects of Astragaloside IV Against the TGF-β1-Induced Epithelial-to-Mesenchymal Transition in Peritoneal Mesothelial Cells by Promoting Smad 7 Expression.
Zhang L; Li Z; He W; Xu L; Wang J; Shi J; Sheng M
Cell Physiol Biochem; 2015; 37(1):43-54. PubMed ID: 26278416
[TBL] [Abstract][Full Text] [Related]
33. Transforming growth factor β1 promotes fibroblast-like synoviocytes migration and invasion via TGF-β1/Smad signaling in rheumatoid arthritis.
Zhu D; Zhao J; Lou A; Huang Q; OuYang Q; Zhu J; Fan M; He Y; Ren H; Yang M
Mol Cell Biochem; 2019 Sep; 459(1-2):141-150. PubMed ID: 31297660
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-422a functions as a tumor suppressor in non-small cell lung cancer through SULF2-mediated TGF-β/SMAD signaling pathway.
Li WQ; Zhang JP; Wang YY; Li XZ; Sun L
Cell Cycle; 2019 Aug; 18(15):1727-1744. PubMed ID: 31204561
[TBL] [Abstract][Full Text] [Related]
35. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
Sun XD; Liu XE; Huang DS
Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
[TBL] [Abstract][Full Text] [Related]
36. LASP1 Induces Epithelial-Mesenchymal Transition in Lung Cancer through the TGF-
Xue Q; Jiang H; Wang J; Wei D
Can Respir J; 2021; 2021():5277409. PubMed ID: 34912481
[TBL] [Abstract][Full Text] [Related]
37. PEITC inhibits the invasion and migration of colorectal cancer cells by blocking TGF-β-induced EMT.
Xiao J; Zhou N; Li Y; Xiao Y; Chen W; Ye J; Ma T; Zhang Y
Biomed Pharmacother; 2020 Oct; 130():110743. PubMed ID: 34321176
[TBL] [Abstract][Full Text] [Related]
38. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H
Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA XIST regulates the EGF receptor to promote TGF-β1-induced epithelial-mesenchymal transition in pancreatic cancer.
Zou L; Chen FR; Xia RP; Wang HW; Xie ZR; Xu Y; Yu JH; Wang KH
Biochem Cell Biol; 2020 Apr; 98(2):267-276. PubMed ID: 31013436
[TBL] [Abstract][Full Text] [Related]
40. KLF17 empowers TGF-β/Smad signaling by targeting Smad3-dependent pathway to suppress tumor growth and metastasis during cancer progression.
Ali A; Zhang P; Liangfang Y; Wenshe S; Wang H; Lin X; Dai Y; Feng XH; Moses R; Wang D; Li X; Xiao J
Cell Death Dis; 2015 Mar; 6(3):e1681. PubMed ID: 25766320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
